Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design
Crossref DOI link: https://doi.org/10.1208/s12248-016-9892-3
Published Online: 2016-02-24
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maass, Katie F.
Kulkarni, Chethana
Betts, Alison M.
Wittrup, K. Dane
Text and Data Mining valid from 2016-02-24